Electromedical Technologies, Inc. — Cyborg Score 3/10
Challenged
Bioelectronics medical devices for pain management
Strategic Profile
Electromedical develops and manufactures FDA-cleared electrotherapy devices designed for pain management, with its flagship product WellnessPro Plus providing safe, non-invasive therapy for chronic and acute pain without drugs or invasive procedures. In 2025, Electromedical made meaningful progress in simplifying its capital structure and positioning the company for sustainable growth.
Cyborg Score Rationale
As of March 2026, Electromedical Technologies had a market cap of $746K with 3.73 billion shares outstanding. In 2023, revenue was $1.35 million with losses of $2.64 million. The company is heavily diluted and financially stressed, though it is pursuing financial restructuring and new partnerships.
Top Insights
Company developing WellnessPro POD, a compact clinical-grade wearable device for pain management, and Wellness ION Pen, an interferential cold laser for targeted frequency stimulation.
Established partnership with Lionheart Health, which won the Abbvie Allergan Aesthetics ULP Golden Passport Award and is an official entrant in the $101 million XPRIZE competition.
In 2025, made meaningful progress in simplifying capital structure and positioning for sustainable growth.
Founded in 2002 and headquartered in Scottsdale, Arizona.
Named Competitors
TENS Units — Traditional transcutaneous electrical nerve stimulation devices
Prescription Pain Management — Opioid and non-opioid pain relief medications
Physical Therapy Devices — Rehabilitation and physical therapy equipment
Recent Developments
(August 2025) Issued mid-year update highlighting financial restructuring, regulatory alignment, and strategic progress to strengthen financial position
(August 2024) Achieved 17% revenue growth year-over-year for 2023 and completed product development for WellnessPro Infinity™ with iDNA technology
(2023) Revenue reached $1.35 million, representing 17% increase over prior year, with net losses reducing to $2.64 million
Open the full interactive Electromedical Technologies, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.